Expleo Solutions Ltd
Expleo Solutions Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
What the Q4 FY26 call signalled
2 of 4 strong
The short version
Expectation of sustainable double-digit revenue growth in FY '27 despite uncertainties. FY ’26 reported 8.1% revenue growth to INR 11,080 million; however, constant currency revenue slightly declined by 0.4%.
From Expleo Solutions Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Expectation of sustainable double-digit revenue growth in FY '27 despite uncertainties.
- Growth driven by four key levers: new logo acquisition, growing existing accounts, sector focus (payments and aerospace defense), and people investments.
- Strong pipeline validated by increased demand, exemplified by new facility for aerospace defense test bench manufacturing.
- Revenue from aerospace and defense expected to grow due to Make in India initiatives and geopolitical factors, though timing of manufacturing monetization remains uncertain.
- Expansion into new geographies like Egypt, leveraging Middle East success, to fuel new business growth.
- Increased adoption of AI expected to influence 60% of revenue by expanding scope with existing clients, though it pressures ticket sizes.
2 more points from Expleo Solutions Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Expleo Solutions Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Expleo Solutions Limited inaugurated a new, larger facility in Bangalore to support increasing aerospace and defense demand, particularly for test bench production.
- The new facility includes a lab to meet higher test bench production requirements.
- There is a focus on investments in the payments sector, including the development of simulators compatible with Mastercard, Visa, RuPay, American Express, and UPIs, anticipating regulatory deadlines in 2028.
- The company is pursuing an aggressive partner-led growth strategy with over 15 partners for joint go-to-market activities globally, indicating possible strategic investments in partnerships.
2 more points from Expleo Solutions Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in IT - Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Expleo Solutions Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly provide specific details on the current or expected order book or pending orders for Expleo Solutions Limited.
- However, it indicates a strong pipeline validated by acquisition of a larger lab and a new state-of-the-art facility in Bangalore, primarily driven by increasing demand in aerospace and defense sectors.
- There is strong demand from aerospace defense, especially due to "Make in India" initiatives and manufacturing activities for aircraft like Rafale, Boeing, Airbus, and Dassault Aviation, though actual manufacturing timelines have been delayed.
- AI-infused services are expanding in BFSI and technology sectors, driving continuous business growth and renewals.
2 more points from Expleo Solutions Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Expleo Solutions Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹286 Cr, net profit ₹42 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Expleo Solutions's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q1 FY23 earnings call →
Others in IT - Services this season
- Enser (Q4 FY26)
Revenue from operations for H2FY26: ₹57.37 Cr, up 49% YoY from H2FY25 ₹38.46 Cr. Key investor presentation takeaways from Enser's Q4 FY26 investor presentation
- Vakrangee (Q4 FY26)
Q4 FY2025-26 Total Income: ₹5,886.0 Lakhs, down 9.1% YoY from ₹6,473.1 Lakhs in Q4 FY2024-25 (Page 6). Key investor presentation takeaways from Vakrangee Ltd's
- Matrix Geo Sol. (Q4 FY26)
FY26 revenue was INR 40.1 crores, with 81.5% YoY growth. Key concall takeaways from Matrix Geo Sol.'s Q4 FY26 earnings call — and how it ranks against sector…
- Unified Data (Q4 FY26)
Revenue from Operations for H2 FY26: ₹138.97 Cr, up 21.47% YoY from ₹114.41 Cr in H2 FY25 (Page 26). Key concall takeaways from Unified Data- Tech Solutions…
Arthneeti Pro · Annual
Expleo Solutions Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Expleo Solutions Ltd Q4 FY26 results?
Expectation of sustainable double-digit revenue growth in FY '27 despite uncertainties. FY ’26 reported 8.1% revenue growth to INR 11,080 million; however, constant currency revenue slightly declined by 0.4%.
What is Expleo Solutions Ltd share price analysis?
Expleo Solutions Ltd currently shows a below-average growth signal. The stock trades at a P/E of 8.6 with a market cap of ₹1,266 Cr. Investors should review the full earnings analysis for detailed insights.
Is Expleo Solutions Ltd planning capital expenditure?
Expleo Solutions Limited inaugurated a new, larger facility in Bangalore to support increasing aerospace and defense demand, particularly for test bench production.
Keep Expleo Solutions Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.